Coya Therapeutics, Inc. is a biotechnology company focused on developing innovative therapies for neurodegenerative diseases, with an emphasis on conditions such as ALS and Alzheimer's disease

The company leverages proprietary technology platforms to create treatments aimed at modulating the immune system and protecting neuronal health. By harnessing the potential of its unique approaches, Coya aims to improve the quality of life for patients suffering from debilitating neurological disorders while advancing the field of neurotherapeutics. Through rigorous research and development, the company strives to bring new hope to patients and their families by addressing unmet medical needs in the neurodegenerative space.